Why Surrogacy Laws Must Be Established — the Story of the Ott-Dahls
By Keston Ott-Dahl,
HuffPost
| 03. 18. 2016
Untitled Document
When my partner Andrea became a surrogate for another lesbian couple we had no idea we would end up starting over as new parents, especially to a child who has Down Syndrome (a disability which once scared the living daylights out of me) or that our lives would forever be changed — for the better.
But that is exactly what happened and our tale is likely to repeat itself as more and more LGBT couples use surrogates to create their families. You can chose the perfect egg donor or the perfect sperm donor and your baby still may not be as you anticipated, but they are in fact perfect just as they are.
Andrea, the two intended mothers and I had gone through so much to make the baby using Andrea’s eggs and donated sperm. It took 7 emotional months filled with zany characters, and highs and lows that we never expected, but finally we were pregnant. The intended Momma’s were so happy they nicknamed their baby girl, “Peanut.” The 4 of us were on a balloon headed...
Related Articles
By Jacob M. Apel, The Baltimore Sun | 08.16.2024
By Neha Kondaveeti, The Austin Chronicle | 08.16.2024
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...